Castle Biosciences's market cap is currently $658.78M. The company's EPS TTM is $0.15; its P/E ratio is 30.59; Castle Biosciences is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
